Company News

Global Reach

DMS is a proud new member of the Asian Drug Utilization Research Group (DURG).  The Asian Drug Utilization Research Group (www.asiandurg.com) is a new regional network under the International Society for Pharmacoepidemiology’s (ISPE’s) Drug Utilization and Health Service Research (DUR/HSR) special interest group (SIG). The Asian DURG group met at the recent 2018 ISPE conference in Prague, Czech Republic (August 22-26th, 2018) to discuss multi-national research collaboration and international cooperation in drug utilization research (DUR), health services research (HSR) and evidence-based pharmaceutical policy research across countries in Asia.

DMS recently completed a workshop series on Machine Learning applications to the pharmaceutical industry.

DMS has developed two courses for SAS’s Real World Evidence learning path and recently release an e-learning version of the course on Propensity Score Matching, Heckman’s 2-stage model, Interrupted Time Series and Regression Discontinuity.

We are pleased to announce the following new collaborations:

Maple Health Group LLC, which is a company that specializes in health economic modeling analyses.

MetaEvidence LLC, which is a company that specializes in literature synthesis and meta-analytic research.

Impetus Health LLC, which is a company that specializes in pricing and market access activities.

The Rheumatoid Arthritis Support Network is an organization that provides information about RA to their patients, an area of research for DMS.

DMS continues to partner with SAS in delivering high quality statistics classes.  For this year’s schedule of Business Knowledge Series courses developed by DMS please see the SAS training page

 

65 East 3rd Street Suite 1R
New York, NY 10003
Phone: (917) 576-4927

E-mail: howard@datamedsolutions.com